HWGB granted licence to import, distribute healthcare products, medication and vaccines

KUALA LUMPUR: Ho Wah Genting Bhd (HWGB), through its wholly-owned subsidiary HWGB Biotech Sdn Bhd (HWGB Biotech) has been successfully granted the pharmacist’s poisons licence (type A license) from the Pharmaceutical Services Division of Ministry of Health Malaysia.

The licence enables the company to import, store and deal generally by wholesale all controlled medicine (termed as poison according to Poisons Act Malaysia).

“We are delighted to have obtained the license which make us qualify to handle import and distribute our healthcare products in compliance with the Ministry of Health (MOH) regulations,” HWGB Biotech’s Medical and Pharmaceutical Research general manager Dr Yaman Walid Kassab expressed.

“This license shows that we are committed in our healthcare related business and we believe that this license can bring a huge growth potential to HWGB as well.

“With the granted license, we believe that the consumer will be able to trust the product that we are going to distribute such as vaccines and controlled medicine.

“This is because only a pharmacist registered with the Pharmacy Board of Malaysia or a qualified pharmacist recognised by the state health directors of Sabah or Sarawak is able to hold for such license.”

HWGB is principally engaged in investment holdings and the provision of management services to its subsidiaries.

The company had on June 30, 2020 diversified its existing businesses to include healthcarerelated industry which mainly involved in Health Supplement, Biotechnology and Health Technology.